Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amrita Sil

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Indian Journal of Dermatology|November 9, 2020
Bio-Medical Research in COVID-19 TimesAmrita Sil, Nilay K Das, Dwijendra N Gangopadhyay
Indian Dermatology Online Journal|September 24, 2019
Selection of Control, Randomization, Blinding, and Allocation ConcealmentAmrita Sil, Piyush Kumar, Rajesh Kumar, et al.
International Journal of Dermatology|June 23, 2015
Effectiveness and safety of clofazimine and pentoxifylline in type 2 lepra reaction: a double-blind, randomized, controlled studyKunal Roy, Amrita Sil, Nilay K Das, et al.
Indian Journal of Pharmacology|October 10, 2014
Steven's Johnson syndrome with toxic epidermal necrolysis due to thalidomide in a case of multiple myelomaAnupam Das, Amrita Sil, Vivek Mishra, et al.
Journal of Family Medicine and Primary Care|November 20, 2019
Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?Dwaipayan Sarathi Chakraborty, Avijit Hazra, Amrita Sil, et al.
Indian Journal of Dermatology, Venereology and Leprology|October 16, 2020
Exploring the safety and effectiveness of subcutaneous autologous serum therapy versus conventional intramuscular autologous serum therapy in chronic urticaria: An observer-blind, randomized, controlled studyAdrija Datta, Somodyuti Chandra, Abanti Saha, et al.
Indian Journal of Dermatology, Venereology and Leprology|June 8, 2019
A double-blind, randomized controlled trial to compare the effectiveness and safety of purified protein derivative of tuberculin antigen with <i>Mycobacterium w</i> vaccine in the treatment of multiple viral wartsSomodyuti Chandra, Amrita Sil, Adrija Datta, et al.
Indian Journal of Dermatology|April 29, 2021
Therapeutic Modalities in Post Kala-azar Dermal Leishmaniasis: A Systematic Review of the Effectiveness and Safety of the Treatment OptionsAdrija Datta, Indrashis Podder, Anupam Das, et al.
Indian Journal of Dermatology|May 8, 2023
A Cross-Sectional Study of the Levels of Cytokines IL-6, TNF-α, and IFN-γ in Blood and Skin (Lesional and Uninvolved) of Vitiligo Patients and their Possible Role as BiomarkersAbhishek De, Nidhi Choudhary, Amrita Sil, et al.
Indian Journal of Dermatology, Venereology and Leprology|June 29, 2017
Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trialTushar Kanti Sarkar, Amrita Sil, Santasmita Pal, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Indian Journal of Dermatology|November 9, 2020
Bio-Medical Research in COVID-19 TimesAmrita Sil, Nilay K Das, Dwijendra N Gangopadhyay
Indian Dermatology Online Journal|September 24, 2019
Selection of Control, Randomization, Blinding, and Allocation ConcealmentAmrita Sil, Piyush Kumar, Rajesh Kumar, et al.
International Journal of Dermatology|June 23, 2015
Effectiveness and safety of clofazimine and pentoxifylline in type 2 lepra reaction: a double-blind, randomized, controlled studyKunal Roy, Amrita Sil, Nilay K Das, et al.
Indian Journal of Pharmacology|October 10, 2014
Steven's Johnson syndrome with toxic epidermal necrolysis due to thalidomide in a case of multiple myelomaAnupam Das, Amrita Sil, Vivek Mishra, et al.
Journal of Family Medicine and Primary Care|November 20, 2019
Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?Dwaipayan Sarathi Chakraborty, Avijit Hazra, Amrita Sil, et al.
Indian Journal of Dermatology, Venereology and Leprology|October 16, 2020
Exploring the safety and effectiveness of subcutaneous autologous serum therapy versus conventional intramuscular autologous serum therapy in chronic urticaria: An observer-blind, randomized, controlled studyAdrija Datta, Somodyuti Chandra, Abanti Saha, et al.
Indian Journal of Dermatology, Venereology and Leprology|June 8, 2019
A double-blind, randomized controlled trial to compare the effectiveness and safety of purified protein derivative of tuberculin antigen with <i>Mycobacterium w</i> vaccine in the treatment of multiple viral wartsSomodyuti Chandra, Amrita Sil, Adrija Datta, et al.
Indian Journal of Dermatology|April 29, 2021
Therapeutic Modalities in Post Kala-azar Dermal Leishmaniasis: A Systematic Review of the Effectiveness and Safety of the Treatment OptionsAdrija Datta, Indrashis Podder, Anupam Das, et al.
Indian Journal of Dermatology|May 8, 2023
A Cross-Sectional Study of the Levels of Cytokines IL-6, TNF-α, and IFN-γ in Blood and Skin (Lesional and Uninvolved) of Vitiligo Patients and their Possible Role as BiomarkersAbhishek De, Nidhi Choudhary, Amrita Sil, et al.
Indian Journal of Dermatology, Venereology and Leprology|June 29, 2017
Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trialTushar Kanti Sarkar, Amrita Sil, Santasmita Pal, et al.
Pageof 6